Gain Therapeutics's total assets for Q2 2025 were $9.83M, a decrease of -15.40% from the previous quarter. GANX total liabilities were $6.14M for the fiscal quarter, a 5.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.